Effect of ibopamine on peripheral haemodynamics
- PMID: 6873134
- DOI: 10.1007/BF00542205
Effect of ibopamine on peripheral haemodynamics
Abstract
Peripheral haemodynamics was studied in healthy volunteers by strain gauge plethysmography after administration of ibopamine (IB), diisobutyric ester of N-methyl-dopamine, an orally active dopaminergic agonist. Seven subjects received a single oral dose of ibopamine of 150 mg and 6 received a daily dose of 150 mg (50 mg t.i.d.) for 5 consecutive days. Arterial resting blood flow and venous capacity increased and peripheral resistance decreased significantly. Six further subjects were then studied; 3 h after an oral dose of ibopamine 150 mg, the parenteral administration of Sulpiride 50 mg, a specific vascular dopaminergic antagonist, was found significantly to counteract its peripheral activity. Heart rate and arterial blood pressure were never affected and tolerability was good.
Similar articles
-
Effects of ibopamine on peripheral hemodynamics: a strain gauge plethysmographic study in patients with congestive heart failure.Arzneimittelforschung. 1986 Feb;36(2A):380-2. Arzneimittelforschung. 1986. PMID: 3707654
-
[Preliminary evaluation of the effect of ibopamine on the secretion of prolactin].Boll Soc Ital Biol Sper. 1983 Nov 30;59(11):1631-5. Boll Soc Ital Biol Sper. 1983. PMID: 6667307 Italian.
-
Evaluation of acute hemodynamic effects and pharmacokinetic behaviour of ibopamine in patients with severe heart failure.Arzneimittelforschung. 1986 Feb;36(2A):349-54. Arzneimittelforschung. 1986. PMID: 3707648
-
Pharmacological profile of ibopamine. A summary of experiments on anaesthesized dogs.Cardiology. 1990;77 Suppl 5:22-9. doi: 10.1159/000174692. Cardiology. 1990. PMID: 1980631 Review.
-
Ibopamine. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.Drugs. 1988 Jul;36(1):11-31. doi: 10.2165/00003495-198836010-00003. Drugs. 1988. PMID: 3063492 Review.
Cited by
-
Early cardiovascular changes with ibopamine: evidence for a biphasic haemodynamic action.Br J Clin Pharmacol. 1987 Oct;24(4):435-42. doi: 10.1111/j.1365-2125.1987.tb03195.x. Br J Clin Pharmacol. 1987. PMID: 3689625 Free PMC article.
-
Haemodynamic evaluation of ibopamine in severe congestive heart failure.Eur J Clin Pharmacol. 1984;26(1):19-22. doi: 10.1007/BF00546702. Eur J Clin Pharmacol. 1984. PMID: 6714289
-
Acute haemodynamic effects of ibopamine in patients with severe congestive heart failure.Br J Clin Pharmacol. 1985 May;19(5):613-8. doi: 10.1111/j.1365-2125.1985.tb02688.x. Br J Clin Pharmacol. 1985. PMID: 4005102 Free PMC article.
-
Investigation of a possible pharmacokinetic interaction between ibopamine and isosorbide-5-mononitrate.Eur J Clin Pharmacol. 1992;42(5):549-52. doi: 10.1007/BF00314867. Eur J Clin Pharmacol. 1992. PMID: 1607003
-
Acute effect of ibopamine and isosorbide mononitrate on blood volume distribution in congestive heart failure.Eur J Clin Pharmacol. 1994;47(4):325-30. doi: 10.1007/BF00191163. Eur J Clin Pharmacol. 1994. PMID: 7875183 Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources